J.P. Morgan Private Wealth Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-12,202
| Closed | -$119K | – | 1302 |
|
|
2017
Q2 | $119K | Hold |
12,202
| – | – | ﹤0.01% | 1182 |
|
|
2017
Q1 | $296K | Hold |
12,202
| – | – | ﹤0.01% | 1074 |
|
|
2016
Q4 | $392K | Sell |
12,202
-5,592
| -31% | -$180K | ﹤0.01% | 898 |
|
|
2016
Q3 | $889K | Buy |
17,794
+2,542
| +17% | +$127K | 0.01% | 618 |
|
|
2016
Q2 | $647K | Sell |
15,252
-1,195
| -7% | -$50.7K | 0.01% | 700 |
|
|
2016
Q1 | $1.08M | Sell |
16,447
-254
| -2% | -$16.7K | 0.01% | 540 |
|
|
2015
Q4 | $1.04M | Hold |
16,701
| – | – | 0.01% | 515 |
|
|
2015
Q3 | $1.12M | Buy |
16,701
+254
| +2% | +$17K | 0.01% | 447 |
|
|
2015
Q2 | $1.6M | Sell |
16,447
-4,130
| -20% | -$402K | 0.02% | 406 |
|
|
2015
Q1 | $1.92M | Hold |
20,577
| – | – | 0.02% | 388 |
|
|
2014
Q4 | $1.83M | Sell |
20,577
-5,415
| -21% | -$481K | 0.02% | 394 |
|
|
2014
Q3 | $1.8M | Buy |
+25,992
| New | +$1.8M | 0.02% | 394 |
|